Toprak, K. Et Al. 2022. SCUBE1 is associated with thrombotic complications, disease severity, and in-hospital mortality in COVID-19 patients. Thrombosis Research , vol.220 , 100-106.

Toprak, K., KAPLANGÖRAY, M., Palice, A., Taşcanov, M. B., İnanır, M., Memioğlu, T., ... Kök, Z.(2022). SCUBE1 is associated with thrombotic complications, disease severity, and in-hospital mortality in COVID-19 patients. Thrombosis Research , vol.220, 100-106.

Toprak, Kenan Et Al. "SCUBE1 is associated with thrombotic complications, disease severity, and in-hospital mortality in COVID-19 patients," Thrombosis Research , vol.220, 100-106, 2022

Toprak, Kenan Et Al. "SCUBE1 is associated with thrombotic complications, disease severity, and in-hospital mortality in COVID-19 patients." Thrombosis Research , vol.220, pp.100-106, 2022

Toprak, K. Et Al. (2022) . "SCUBE1 is associated with thrombotic complications, disease severity, and in-hospital mortality in COVID-19 patients." Thrombosis Research , vol.220, pp.100-106.

@article{article, author={Kenan Toprak Et Al. }, title={SCUBE1 is associated with thrombotic complications, disease severity, and in-hospital mortality in COVID-19 patients}, journal={Thrombosis Research}, year=2022, pages={100-106} }